drugset / Trial / NCT02871648

The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production

NCT02871648

Phase 1 Completed 23 enrolled Brigham and Women's Hospital
RandomizedCrossoverDouble-blindOther

Summary

The purpose of this research protocol is to determine if the same effects are observed in vivo in humans using a similar approach. Demonstrating that mineralocorticoid acts on zona glomerulosa cells to regulate aldosterone production in a short feedback loop would provide important insight into hormone regulation, and explain variability in pathophysiologic states such as hypertension and cardiovascular diseases.

Timeline

Start
2016-01
Primary completion
2019-10
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eplerenone Unknown 100 mg
Comparator Fludrocortisone Other / unclassified 0.1 mg

Indications

No indication recorded.